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NEW & NOTEWORTHY

A novel mechanism contributing to a faster (at lower OXPHOS deficiencies) and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart, namely a much higher cytosolic inorganic phosphate (P i) accumulation that causes muscle fatigue even at low/moderate exercise intensity, is proposed.
A DECREASE IN THE OXIDATIVE phosphorylation (OXPHOS) activity related to mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) can lead to impairment of energy metabolism in different tissues. This takes place in the case of mitochondrial diseases related to OXPHOS (complex) deficiencies (9, 13, 40, 42, 57, 61, 63) . Deficiencies in particular complexes are caused by point mutations in genes encoding OXPHOS complex subunits (8, 13, 61, 63) . Dysfunction of entire OXPHOS is related to point mutations in mitochondrial tRNA or rRNA genes (13, 61, 63) , large deletions (13, 61, 63) (both affecting protein synthesis in general), or mutations in genes affecting the number of (wild-type) mtDNA copies (63) . Most mitochondrial diseases are related to entire OXPHOS deficiencies affecting most or all of its complexes (54, 58, 61) .
A very characteristic property of mitochondrial diseases is tissue specificity (3, 11, 40, 42, 49, 51, 54, 58, 61, 63, 64) . Namely, statistically some tissues are more vulnerable to OXPHOS (complex) deficiencies, and mitochondrial diseases manifest preferentially (that is, at lower levels of OXPHOS dysfunction and with greater intensity) in them. Usually, the brain and skeletal muscle are affected more severely and at higher relative OXPHOS activities than other tissues. Heart, endocrinal tissues, and kidney are affected to a lesser extent, while liver, skin, bone, and connective tissues manifest mitochondrial diseases only exceptionally. Wallace (61) ordered selected tissues/organs from most to least prone to mitochondrial diseases: brain Ͼ skeletal muscle Ͼ heart Ͼ kidney Ͼ lung. Frequently, the same mutation can result in different syndromes, depending, for example, on the fraction of mutated DNA molecules or their distribution among different tissues, while different mutations can cause the same syndrome (49, 63) .
Several possible causes of the tissue specificity of mitochondrial diseases have been proposed: different proportion of mutated mtDNA in different tissues (54, 62, 63) ; specificity of the effect of different mutations in different tissues (40, 54) ; different wild-type levels of enzymes affecting the amount of (normal) mtDNA and OXPHOS complexes (11, 62) ; preferential development of mitochondrial diseases in tissues that have the highest maximal ATP demand/turnover in relation to their OXPHOS capacity (61, 64) . Additionally, tissue specificity of mitochondrial diseases related to point mutations in genes encoding particular OXPHOS complex subunits can be a derivative of different relative amount/activity of particular complexes (3, 8, 49) .
Mitochondrial diseases are characterized by a threshold value of wild-type mtDNA and OXPHOS (complex) activity below which a disease manifests (49, 62) . This threshold is frequently as low as Ͻ10% of wild-type mtDNA molecules number/OXPHOS activity (9, 54, 63) . The threshold was related to the threshold in OXPHOS complex activities in state 3 in isolated mitochondria, below which oxygen consumption starts to fall abruptly with a decrease in the complex activity (39, 50) .
It was demonstrated in a recent theoretical study (32) , using the model version for isolated mitochondria (34) vs. version for intact skeletal muscle (33) , that isolated skeletal muscle mitochondria in state 3 are not a satisfactorily good model of OXPHOS deficiencies in the intact working skeletal muscle bioenergetic system, as threshold values of OXPHOS complex activity and metabolite concentrations (especially the extramitochondrial ATP/ADP ratio) are unphysiological in the former case. Additionally, it was shown that metabolite [cytosolic ADP, phosphocreatine (PCr), P i , proton motive force (⌬p)] and cytosolic H ϩ concentrations start to change significantly at much higher OXPHOS (complex) activities than oxygen consumption (V O 2 ) at a given (moderate or high) ATP demand in working skeletal muscle. In other words, the threshold values of OXPHOS (complex) activities are much higher for metabolites and pH than for V O 2 . Consequently, it was postulated that not a decrease in V O 2 and oxidative ATP production per se, but first of all an increase in cytosolic P i , ADP, and H ϩ , considered as the most important fatigue-inducing factors in skeletal muscle, is responsible for the genesis and etiology of mitochondrial myopathies (32) .
It was proposed that the main mechanism responsible for the regulation of the bioenergetic system during work transitions in skeletal muscle and heart (and other tissues) is a direct eachstep activation (ESA) of all OXPHOS complexes, NADH supply, and glycolysis (caused by some mechanism related to, mostly cytosolic, Ca 2ϩ and protein phosphorylation), in parallel with the activation of ATP usage (mostly actomyosinATPase and Ca 2ϩ -ATPase) by Ca 2ϩ (26-31, 35, 36) . It was postulated that while in intact heart in vivo this is the only relevant mechanism (35, 28) , as cytosolic ADP, PCr, P i , and NADH remain essentially constant during low-to-high work transitions (2, 21, 23, 56) , in skeletal muscle it cooperates with the negative feedback through cytosolic ADP and P i , as their concentrations increase moderately during rest-to-work transition (mixed mechanism) (30) . This is because, in heart, ATP supply is activated through ESA to the same extent as ATP demand, while in skeletal muscle, ATP usage is activated more than ATP supply (through ESA). A similar mechanism, called "multisite modulation," was proposed in a more abstract and general way by Fell and Thomas (14) in relation to other metabolic pathways, especially glycolysis. Such a mechanism was recently partly confirmed by Glancy et al. (16) , who encountered an about twofold activation of all OXPHOS complexes by Ca 2ϩ in isolated skeletal muscle mitochondria incubated with glutamate/malate (computer simulations suggest that a direct at least fivefold activation of all system components is needed; 36). A simultaneous activation of the ATP demand and ATP supply system as a whole was proposed by Hochachka (22) . This proposal was recently supported by Wüst et al. (67) . However, the authors did not determine which and how many elements of the ATP supply system are directly activated.
It was observed that OXPHOS deficiencies related to mitochondrial myopathies (MM) slow down significantly the pulmonary V O 2 on-kinetics in humans at moderate-intensity external (loaded) work (18) . The term "moderate" was used there in relation to the maximum external work that was over twice lower in MM patients than in control healthy subjects. However, the total ATP demand has not been estimated in this study. The external work (power output) cannot be identified with or assumed to be strictly proportional to ATP usage, oxidative ATP supply, or V O 2 (see DISCUSSION) .
It is regarded that cytosolic inorganic phosphate (P i ) and, to a lesser extent, cytosolic ADP and H ϩ are mostly responsible for exertional fatigue (1, 12, 19, 43, 65) (55) .
In the present theoretical study the computer model of OXPHOS and the whole muscle bioenergetic system (model versions for skeletal muscle and heart; 33, 35) are used to compare the effect of the 80% of OXPHOS deficiency (decrease of OXPHOS activity to 20% of normal) on the bioenergetic system in skeletal muscle and heart at moderate ATP demand. It is assumed that OXPHOS deficiency is identical in skeletal muscle and heart. It is hypothesized that a new mechanism, in addition to the potential causes enumerated above, can contribute to the tissue specificity of mitochondrial diseases, namely a much higher cytosolic inorganic phosphate (P i ) concentration (possibly together with higher cytosolic ADP and H ϩ concentrations) at low OXPHOS activity in skeletal muscle than in heart. As cytosolic P i (and, to a lesser extent, ADP and H ϩ ) was postulated to be the most important fatigueeliciting factor in skeletal muscle (1, 12, 19, 43, 53, 65) and potential force generation-limiting factor in heart (60), it is proposed that this system property can contribute to the faster (at higher OXPHOS activities) and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart. In other words, at large OXPHOS deficiencies, skeletal muscle, but not heart, becomes fatigued already at low/moderate work intensity, because of large cytosolic P i accumulation. Such a large accumulation does not take place in heart because of the much smaller total phosphate pool than in skeletal muscle. However, other factors/mechanisms responsible for the tissue specificity of mitochondrial diseases, among them those enumerated above, are likely to also contribute to this specificity.
METHODS
Computer model. The computer model of OXPHOS and entire bioenergetic system in skeletal muscle (33, 37) and heart (35) including anaerobic glycolysis developed previously was used in the present study. This model comprises particular oxidative phosphorylation (OXPHOS) complexes (complex I, complex III, complex IV, ATP synthase, ATP/ADP carrier, P i carrier), proton leak, (anaerobic) glycolysis, creatine kinase (CK), ATP usage, NADH supply, and proton efflux/influx to/from blood.
The model has been broadly validated by comparison of its predictions with various experimental data and used for numerous theoretical studies [see, e.g., and Korzeniewski and Rossiter (36) for overview]. Among others, what is particularly important in the context of the present study is that the version of the model for isolated skeletal muscle mitochondria has been tested for the values of flux control coefficient and the shapes of whole inhibitor titration/threshold curves of OXPHOS complexes in isolated skeletal muscle mitochondria in state 3 (30, 34) . Of course, the predictions of the model version for intact muscle differ from the predictions of the version for isolated mitochondria (32) , as both systems differ significantly from the bioenergetic point of view (31) . The complete model description of the skeletal muscle and heart bioenergetic system including anaerobic glycolysis is located on the Web site: http:// awe.mol.uj.edu.pl/ϳbenio/.
Simulation procedures. In this article the term "100% of OXPHOS activity" is used as a synonym of normal or wild-type "basic" (without ESA) OXPHOS activity. This is equivalent to 100% of normal OXPHOS complex rate constant values. The basic OXPHOS activity is identical at rest, during moderate work (ATP demand), and during intensive work (ATP demand). It is ESA intensity, oxidative ATP production, and V O2 that are different in these states in "normal" (without OXPHOS deficiencies) individuals.
The dependence of selected system variables on the relative entire OXPHOS activity in skeletal muscle during moderate exercise was simulated as in the previous study (32) . During rest-to-moderate exercise (moderate ATP demand) transition the activity of ATP usage was increased A UT ϭ 35 times. This means that the rate constant of ATP usage (kUT) at rest was increased AUT times during moderate work. AUT is a direct measure of the relative ATP hydrolysis for muscle contraction and, therefore, of work intensity. The activities (rate constants) of all OXPHOS complexes and NADH supply were increased A OX ϭ 4.61 (35 0.43 ; the power coefficient P ϭ 0.43 is a measure of ESA intensity) times, and the activity (rate constant) of glycolysis was increased AGL ϭ 22.05 (35 0.7 ) times. This means that during moderate work the rate constants of complex I (kC1), complex III (kC3), complex IV (kC4), ATP synthase (kSN), ATP/ADP carrier (kEX), Pi carrier (kPI), and NADH supply (kDH) were increased AOX times, while the rate constant of glycolysis (kGL) was increased AGL times in relation to rest. The dependence of V O2 and chosen metabolite concentrations on the relative activity of entire OXPHOS was simulated by a gradual decrease in subsequent simulations in the "working" rate constants of all OXPHOS complexes (k C1, kC3, kC4, kSN, kEX, kPI) from 100% to low fraction of the normal ("wild-type") value (below which a collapse of the system took place). In other words, the "wild-type" values of these constants during moderate work were multiplied by the fraction of "normal" OXPHOS activity (for instance, by 0.2 for 20% of normal activity).
Within the model, the total phosphate pool in skeletal muscle cells is constant and equals Αphosphate ϭ V cyt (3 ATPcyt ϩ 2 ADPcyt ϩ AMP ϩ Picyt ϩ PCr) ϩ Vmit (3 ATPmit ϩ 2 ADPmit ϩ Pimit) ϭ 52.4 mM, where subscript cyt means cytosolic, subscript mit means mitochondrial, V cyt ϭ 0.933 is the relative cytosol volume (fraction of the cell volume), and Vmit ϭ 0.067 is the relative mitochondria volume (fraction of the cell volume). The total creatine pool (PCr ϩ Cr) in skeletal muscle is 35 mM.
In intact heart in vivo at medium work (moderate ATP demand) the activation of the system components (in relation to low work) was as follows: A UT ϭ 1.7, AOX ϭ 1.61, AGL ϭ 1.61. This means that appropriate rate constants were multiplied by these activation values (see above). The relative activation for medium work was chosen to give a similar V O2 and ATP demand as in skeletal muscle during moderate exercise. The dependence of selected system variables on the OXPHOS activity was simulated similarly to that for skeletal muscle.
Within the model, the total phosphate pool in heart cells is constant and equals Αphosphate ϭ V cyt (3 ATPcyt ϩ 2 ADPcyt ϩ AMP ϩ Picyt ϩ PCr) ϩ Vmit (3 ATPmit ϩ 2 ADPmit ϩ Pimit) ϭ 37.5 mM, where subscript cyt means cytosolic, subscript mit means mitochondrial, V cyt ϭ 0.770 is the relative cytosol volume (fraction of the cell volume), and Vmit ϭ 0.230 is the relative mitochondria volume (fraction of the cell volume). The total creatine pool (PCr ϩ Cr) in heart is 25 mM.
Time courses of V O2, selected metabolite concentrations, as well as ATP supply and usage fluxes in skeletal muscle for rest-to-moderate exercise (ATP demand) transition and in heart for low-to-medium work (ATP demand) transition for 100 and 20% of normal OXPHOS activity were simulated through an appropriate activation of the system (see the values of A UT, AOX, and AGL given above) after 2 min of simulations. (At rest in skeletal muscle and during low work in heart no activation of the system took place: A UT ϭ 1, AOX ϭ 1, AGL ϭ 1.) While the increase in AUT was instantaneous, the increase in AOX and AGL followed an exponential time course, with a characteristic activation time equal to 3 s for AOX and 6 s for AGL (28, 36) . Simulations were continued for the next 6 min, to the eighth minute.
To calculate half-transition times t 1/2 for different OXPHOS activities in skeletal muscle, simulations concerning the rest-to-moderate work (ATP demand) transition were repeated for different OXPHOS activities between 100 and 20% of the normal value. 2). The absolute PCr level is somewhat higher in skeletal muscle (16.4 mM) than in heart (12.1 mM) because of the higher total creatine pool (PCr ϩ Cr ϭ 35 mM) (and high resting PCr level) in this tissue than in heart (PCr ϩ Cr ϭ 25 mM). These values are typical for skeletal muscle during moderate work (10, 52) and for heart (25), respectively. Different metabolite concentrations are essentially identical in heart at low, medium, and high work/ATP demand [not shown; see Korzeniewski (28) and Korzeniewski et al. (35) ]; this is caused by a "perfect" ESA in this tissue (see introductory text).
RESULTS
V O
The main difference between skeletal muscle and heart at 100% of normal OXPHOS activity is a much higher cytosolic P i concentration in the former than in the latter (12.3 vs. 2.6 mM) (Table 1, Figs. 1 and 2). These values are typical for skeletal muscle during moderate work (10, 15) and within the range encountered in heart (24, 25, 46) , respectively. The discussed difference derives from high resting PCr concentration equal to 28.8 mM (and high total creatine and phosphate pools) in skeletal muscle. During rest-to-moderate exercise (ATP demand) transition a large part of PCr is converted to Cr and P i , and its concentration decreases to 16.4 mM, which is associated with cytosolic P i increase from 2.8 to 12.3 mM. In intact heart in vivo, PCr and cytosolic P i are essentially identical at different work intensities, as mentioned above. At 20% of normal OXPHOS activity V O 2 , metabolite concentrations and pH change significantly in relation to 100% of normal OXPHOS activity both in skeletal muscle and heart (Table 1, Figs. 1 and 2). However, significant changes in metabolite and H ϩ concentrations begin earlier (at higher relative OXPHOS activities) than significant decrease in V O 2 [compare Korzeniewski (32) ]. Below some OXPHOS activity the system collapses.
In skeletal muscle at moderate ATP demand, when OX-PHOS activity decreases from 100 to 20% of the wild-type value, V O 2 decreases by only 19%, cytosolic ADP increases from 24.0 to 325 M, PCr decreases from 16.4 to 1.1 mM, cytosolic P i increases from 12.3 to 26.3 mM, and cytosolic H ϩ increases about twice (Table 1 , Fig. 1 ). In heart at moderate ATP demand at 20% of normal OXPHOS activity, V O 2 decreases by 24%, cytosolic ADP increases from 31.9 to 192 M, PCr decreases from 12.1 to 1.6 mM, cytosolic P i increases from 2.6 to 8.3 mM, and cytosolic H ϩ increases 2.2 times (Table 1 , Fig. 2 ). NADH seems to be rather little sensitive to OXPHOS activity-it slightly increases at low OXPHOS activities (Table 1 , Figs. 1 and 2 ).
The most striking difference between skeletal muscle and heart at high (80%) OXPHOS deficiency is a much higher cytosolic P i concentration in the former than in the latter (26.3 vs. 8.3 mM) ( Table 1 , Figs. 1 and 2 ). Also cytosolic ADP and H ϩ are higher, while PCr, ⌬p, and mitochondrial NADH are lower in skeletal muscle than in heart, although here the differences are not so big. Additionally, they depend on exact values of V O 2 and ATP turnover (set in the simulations by the relative increase in ATP usage activity A UT , being a measure of work intensity proportional to ATP hydrolysis rate for muscle contraction, during work transitions) assumed for skeletal muscle and heart at "moderate" ATP demand. This does not concern the difference in cytosolic P i concentration, which is similar in heart at different ATP demand values (work intensities). (The term "moderate" or "medium" work is somewhat vague and refers in fact to a quite broad range of states; therefore it is very important to stress that the reasoning made in the present study concerns the whole range, and not just one particular state.) Cytosolic P i level increases at 20% of normal OXPHOS activity in heart to 8. Therefore the exact ATP demand in a broad range of work intensity is not important either in skeletal muscle or in heart. The cytosolic P i level at 20% of normal OXPHOS activity in skeletal muscle and heart does not depend significantly on ATP demand, because under these conditions most PCr is converted to P i and Cr, and a further slight decrease in PCr (even to 0 mM) could result only in a very limited rise in cytosolic P i . The much higher cytosolic P i accumulation in skeletal muscle than in heart is related to a much higher total phosphate pool in the former (52.4 vs. 37.5 mM in heart, see METHODS), higher PCr level at 100% of OXPHOS activity, and lower P i redistribution between cytosol and mitochondria at 20% of normal OXPHOS activity (see DISCUSSION). Generally, cytosolic P i level depends little on the value of energy demand (work intensity) at 20% of normal OXPHOS activity. This concerns also PCr concentration that falls to near/below 1 mM. On the other hand, cytosolic ADP and H ϩ concentrations depend significantly on work intensity (ATP demand). Therefore it is not easy to compare systematically their values between skeletal muscle and heart, because this comparison depends on particular work intensities (ATP demands) chosen. It is not clear which particular ATP demands in skeletal muscle and heart are most relevant for the development of mitochondrial diseases.
It can be seen from Figs. 2 vs. 1 that the above discussion applies to the entire range of OXPHOS activity from 100 to 15% of normal OXPHOS activity. At the same V O 2 and oxidative ATP supply, values of most variables, namely V O 2 , cytosolic ADP, ATP, PCr, and mitochondrial NADH, are rather similar in skeletal muscle and heart at different OX-PHOS activities. The only exception is cytosolic P i , which is much higher in skeletal muscle than in heart at all OXPHOS activities.
V O 2 , metabolite concentrations, and ATP supply/usage fluxes during work transitions at 100 and 20% of normal OXPHOS activity in skeletal muscle and heart. High (80%) OXPHOS deficiency strongly slows down the V O 2 on-kinetics during rest-to-moderate exercise (ATP demand) transition in skeletal muscle. This can be seen in Fig. 3 . The half-transition time t 1/2 for V O 2 is over three times longer (ϳ62 vs. 18 s) for 20% than for 100% of normal OXPHOS activity. V O 2 , metabolite, and H ϩ concentrations are significantly different for 100 and 20% of normal OXPHOS activity before and after transition, as high OXPHOS deficiency significantly weakens metabolite stability. A significant part of ATP supply during work at 20% of normal OXPHOS activity is taken over by anaerobic glycolysis, which is low at 100% of normal OXPHOS activity at moderate ATP demand (Fig. 3, bottom) . Namely, at 80% of OXPHOS deficiency, the contribution of anaerobic glycolysis to ATP supply increased from 9% at normal OXPHOS activity to 26% after 6 min of moderate exercise (with moderate ATP usage). This results in an advancing cytosol acidification. However, glycolysis is self-limited by its product, cytosolic H ϩ (36) , and therefore the increase in cytosolic ADP accelerates for a time during exercise before it reaches the level that activates (anaerobic) glycolysis (and OXPHOS) to an appro- priate extent (Fig. 3) . NADH decreases after the onset of exercise both at 100 and 20% of normal OXPHOS activity.
A qualitatively similar situation takes place in heart, although the transition between work intensities is generally much faster here. Fig. 4 demonstrates that a large OXPHOS deficiency slows down the low-to-medium work transition in relation to control (t 1/2 increases from 3.7 to 5.3 s). However, the relative effect is not as big as in skeletal muscle. While metabolite concentrations and pH are essentially constant during the transition at 100% of normal OXPHOS activity, they change very moderately at 20% of OXPHOS activity. In this situation, t 1/2 is mostly determined by the characteristic time constant of OXPHOS activation (see METHODS). Also, in heart at 20% of normal OXPHOS activity a significant part of ATP supply is taken over by anaerobic glycolysis during both low and medium work. The contribution of anaerobic ATP supply at low and medium work (ATP demand) increased from 0% at normal OXPHOS activity to 26 and 23%, respectively, at 20% of normal OXPHOS activity. As a result, V O 2 and pH decreased (Fig. 4) . NADH is essentially constant in the simulations concerning low-to-moderate transition in heart, both for 100 and 20% of the normal OXPHOS activity. Its time course does not exhibit the "on-undershoot" observed in isolated trabeculae (5) , because the activation of NADH production is not significantly delayed in relation to the activation of NADH consumption (see DISCUSSION) .
The half-transition time for V O 2 during on-transient (t 1/2 ) in skeletal muscle is inversely proportional to OXPHOS activity. The relationship between them is nonlinear. This is demonstrated in Fig. 5 . Since t 1/2 is related to changes in metabolite concentrations during work transitions (38), the t 1/2 -OXPHOS activity dependence is generally similar to the cytosolic P i -OXPHOS activity dependence (and to the inversed PCr-OXPHOS activity dependence) shown in Fig. 1 (compare DISCUSSION Figs. 1 and 2 ). This takes place despite the much higher mitochondria content and "basic" (not elevated by ESA) OXPHOS activity in heart than in skeletal muscle cells: within the model, mitochondria occupy ϳ23% of cardiomyocyte volume and ϳ7% of skeletal myocyte volume. However, ESA is much higher in skeletal muscle during (this particular intensity of) moderate exercise (A OX ϭ 4.61) than in heart during medium work (A OX ϭ 1.61). This compensates for the lower basic (not elevated by ESA) OXPHOS activity in the former. Nevertheless, it should be stressed that the exact value of energy demand and V O 2 at "moderate" work intensity in skeletal muscle and heart can vary in a wide range and is not important for the general conclusions drawn in the present theoretical study. The main difference between the bioenergetic system in skeletal muscle and heart at moderate ATP demand is the much higher cytosolic P i concentration at 100% of normal OXPHOS activity (12.3 vs. 2.6 mM) and, especially, at 20% of normal OXPHOS activity (26.3 vs. 8.3 mM) in the former (Table 1 , Figs. 1 and 2) . This difference is due to a higher PCr level and higher total phosphate pool (52.4 mM in skeletal muscle vs. 37.5 mM in heart) as well as to a much smaller inorganic phosphate (P i ) redistribution between cytosol and mitochondria at OXPHOS deficiency in skeletal muscle than in heart (see below). Because cytosolic P i is considered to be the most important fatigue and force-limiting factor in skeletal muscle (1, 12, 43, 65) , its high levels can contribute significantly to the genesis of myopathies, especially to such of their symptoms as muscle weakness and exercise intolerance (exertional fatigue) (57, 63) . Simply, at large OXPHOS deficiencies, skeletal muscle becomes fatigued already at low/moderate work intensities. In heart, high cytosolic P i levels could potentially lead to development of a disease or even result in heart arrest. Indeed, van der Velden et al. (60) demonstrated that high cytosolic P i decreases significantly the force in isolated cardiomyocytes. However, very high cytosolic P i levels do not appear in intact heart even at large OXPHOS deficiencies because of the total phosphate pool, PCr level at normal OXPHOS activity, and high P i redistribution between cytosol and mitochondria (see below) in cardiomyocytes. It must be stressed that the absolute cytosolic P i concentration, and not its relative changes, is the factor that really matters.
In skeletal muscle the high resting PCr concentration (ϳ28.8 mM in the model), and consequently high total creatine (PCr ϩ Cr) and phosphate pools, is necessary because PCr conversion to Cr catalyzed by creatine kinase (CK) is the main source of ATP at the onset of exercise (Fig. 3) . The PCr concentration is still relatively high at moderate ATP demand (16.4 mM) . In intact heart in vivo no changes in PCr (and cytosolic P i ) take place under normal conditions during work transitions (2, 23; Fig. 4) , and therefore the CK system does not fulfil the above function. For this reason, high PCr, total creatine, and phosphate pools are not needed [PCr concentration in the model equals 12.1 mM at moderate ATP demand, and is very similar at low (Fig. 4 ) and high energy demand (not shown)]. The only role of the creatine kinase system that remains is to overcome possible cytosolic ADP diffusion limitations (the "creatine shuttle"; 4). Therefore the decrease in PCr between 100 and 20% of normal OXPHOS activity is higher in skeletal muscle (⌬PCr ϭ Ϫ15.3 mM) than in heart (⌬PCr ϭ Ϫ10.5 mM).
However, this fact cannot explain entirely the discussed differences in cytosolic P i accumulation at OXPHOS deficiency. Namely, the increase in cytosolic P i between 100 and 20% of normal OXPHOS activity in skeletal muscle is only slightly lower than ⌬PCr and equals ⌬P i ϭ 14.1 mM, while in heart it is as much as about twice lower than ⌬PCr and equals ⌬P i ϭ 5.7 mM (Table 1 ). This is caused by P i redistribution between cytosol and mitochondria when OXPHOS activity decreases from 100 to 20% of the normal value. In skeletal muscle, mitochondria P i concentration increases from 51.2 mM at 100% of OXPHOS activity to 89.3 mM at 20% of OXPHOS activity (⌬P imit ϭ 38.1 mM). [The several times higher P i concentration in mitochondria than in cytosol is caused by the fact that P i is cotransported to mitochondria with H ϩ by the P i carrier and H ϩ concentration is ϳ3 times higher in cytosol than in mitochondrial matrix (⌬pH ϭ ϳ0.5)]. However, mitochondria occupy (within the model) only ϳ7% of the cell volume in skeletal muscle, and therefore P i accumulation in them can only slightly affect the cytosolic P i level. On the other hand, in heart mitochondria, P i concentration increases from 7.0 mM at 100% of normal OXPHOS activity to 26.9 mM at 20% of normal OXPHOS activity (⌬P imit ϭ 19.9 mM). However, mitochondria occupy (within the model) 23% of the cardiomyocyte volume, and the absolute cytosolic P i concentration is much smaller in heart than in skeletal muscle. Therefore the P i redistribution between cytosol and mitochondria caused by OXPHOS dysfunction can affect the cytosolic P i level much more in heart than in skeletal muscle.
Summing up, three factors, namely the higher cytosolic P i level at 100% of normal OXPHOS activity (12.3 vs. 2.6 mM), higher PCr level at 100% of normal OXPHOS activity (16.4 vs. 12.1 mM) (both related to higher total phosphate pool: 52.4 vs. 37.5 mM), and lower P i redistribution between cytosol and mitochondria at 20% of normal OXPHOS activity, cause cytosolic P i to rise to a much higher concentration (26.3 vs. 8.3 mM) in skeletal muscle than in heart at 20% of normal OXPHOS activity.
The lower total phosphate and PCr ϩ Cr pool in heart than in skeletal muscle and the low relative potential P i accumulation in heart mitochondria can be a safety mechanism that protects "wild-type" heart against excessive P i accumulation in cytosol and consequent dysfunction, failure, or arrest during ischemia, when PCr is ultimately converted to Cr and P i (the net reaction of the pair of reactions: PCr ϩ ADP ¡ Cr ϩ ATP and ATP ¡ ADP ϩ P i is PCr ¡ Cr ϩ P i ). This mechanism is also at work in the case of OXPHOS deficiencies, where cytosolic P i also tends to increase.
Also cytosolic ADP and H ϩ can contribute, although to a much lesser extent than cytosolic P i , to fatigue development in skeletal muscle (1, 19, 53, 65) as well as to force decrease in cardiomyocytes (60) . They tend to be higher in skeletal muscle during moderate exercise (ATP demand) than in heart during medium work (ATP demand) at similar V O 2 at 20% of normal OXPHOS activity (for the particular "moderate" ATP demand values used in computer simulations) and therefore can also potentially contribute to the faster and stronger development of mitochondrial diseases in skeletal muscle than in heart. However, their increase between 100 and 20% of normal OXPHOS activity depends on the exact ATP demand (A UT value) and V O 2 in skeletal muscle during "moderate" exercise and in heart during "medium" work (not shown). A UT (multiplicity of the "resting" value of ATP usage activity/rate constant during work) is a measure of (the activity of) ATP consumption for muscle contraction and, therefore, of work intensity. This does not concern the difference in cytosolic P i concentration at high OXPHOS deficiencies, which is similar at different work intensities (ATP demand values) at OXPHOS deficiencies in heart and always rises to high values for a broad range of work intensity (ATP demand) at high OXPHOS deficiencies in skeletal muscle (it always exceeds 20 mM, apart from very low ATP demands, not shown). For instance, in heart, cytosolic P i rises at 80% OXPHOS deficiency to 8.4, 8.9, and 10.0 mM at low, A UT ϭ 1 (resulting in V O 2 ϭ 2.53 mM/min at wild-type OXPHOS activity), medium, A UT ϭ 1.7 (resulting in V O 2 ϭ 4.02 mM/min at wild-type OXPHOS activity), and high, A UT ϭ 4 (resulting in V O 2 ϭ 8.89 mM/min at wild-type OXPHOS activity), ATP demand, respectively. In the case of 80% OXPHOS deficiency in skeletal muscle, cytosolic P i rises to 23.5 mM at A UT ϭ 25 (resulting in V O 2 ϭ 2.84 mM/min at wild-type OXPHOS activity), to 26.3 mM at A UT ϭ 35 (resulting in V O 2 ϭ 3.98 mM/min at wild-type OXPHOS activity), and to 27.7 mM at A UT ϭ 45 (resulting in V O 2 ϭ 5.13 mM/min at wild-type OXPHOS activity) during exercise at 20% of normal OXPHOS activity. Cytosolic P i cannot increase much further both in skeletal muscle and heart, because under these conditions PCr is almost completely converted to P i (and Cr) and there is no significant alternative source of cytosolic P i . For this reason, the cytosolic P i level at high (e.g., 80%) OXPHOS deficiencies remains the main candidate for the bioenergetic-system-related factor responsible for the tissue specificity of mitochondrial diseases in the context of skeletal muscle vs. heart. It simply causes muscle fatigue already at low/moderate work intensities.
Generally, the cytosolic P i level at 20% of normal OXPHOS activity in skeletal muscle and heart does not depend significantly on ATP demand, because under these conditions most PCr is converted to P i and Cr. Therefore the conclusions drawn in the present article do not depend on the exact value of ATP demand and V O 2 assumed in skeletal muscle and heart (apart from a very low ATP demand in skeletal muscle).
High cytosolic P i level can compromise muscle power generation through a decrease in the cross-bridge force production and/or in myofibrillar Ca 2ϩ sensitivity (1). Very high cytosolic P i concentration would terminate the actomyosin-ATPase functioning, and therefore all muscle mechanical work (power generation), because P i release from the myosin head initiates the power stroke, and a very high cytosolic P i level would block this process (1) .
It must be stressed that although the same relative increase in cytosolic ADP, P i , or H ϩ would change the cytosolic phosphorylation potential ⌬G P to the same extent, the action of these metabolites on the ATP supply system (e.g., OXPHOS) and ATP demand block (actomyosin-ATPase and Ca 2ϩ -ATPase) is very different. For instance, OXPHOS is activated much more by the same relative increase in ADP than in P i (at physiological concentrations), and it is essentially insensitive to pH in the physiological range. Different stages of the power stroke by actomyosin-ATPase are dependent on ATP, ADP, or P i . Therefore ⌬G P in general is not a good indicator of the bioenergetic system dysfunction-at the same ⌬G P the system functioning can be seriously compromised in skeletal muscle, but not in heart, depending on the absolute values of particular ⌬G P "components." Only the rate of reactions/processes that are near thermodynamic equilibrium, like complex I or complex III of the respiratory chain or ATP synthase, can be described satisfactorily as a function of thermodynamic potentials (linear proportional flux-force relationship), for instance, of ⌬p. The ATP-consuming processes are far displaced from thermodynamic equilibrium, and therefore such a description does not apply to them [kinetic description is adequate in this case; see, e.g., Rohwer and Hofmeyr (48) ]. Therefore ⌬G P can only be regarded as a crude measure of the cell "energy charge," but it is of little use in kinetic considerations concerning the regulation of both ATP-supply system (especially OXPHOS) and ATPases (in particular, actomyosin-ATPase and Ca 2ϩ -ATPase). For the latter purpose, the ⌬G P "components" ADP, P i , ATP, and H ϩ should be considered separately. Sequeira et al. suggested a significant role of elevated ADP in recruiting cross-bridges and generation of diastolic myocardial stiffness that could contribute to heart failure (55) . While interesting, this study is not easy to interpret. A significant effect of ADP seems to appear at as high concentration as 1 mM. In vivo ADP does not increase above ϳ1.5 mM because of the presence of adenylate kinase that converts ADP to AMP [see, e.g., Liguzinski and Korzeniewski (41)]. No P i is present in the medium with permeabilized cardiac myocytes. Overall, it is not clear at what OXPHOS deficiency the elevated ADP could exert its inhibitory effect.
Other metabolites that accumulate in intensively working skeletal muscle, for instance Cr or IMP, have very small, if any, impact on muscle fatigue (1).
The postulated reasons and role of the difference in cytosolic P i accumulation at low OXPHOS activities for the tissue specificity of mitochondrial diseases in the context of skeletal muscle vs. heart are summarized in Fig. 6 . Simply speaking, it is postulated that skeletal muscle with large OXPHOS deficiencies becomes fatigued, because of high cytosolic P i accumulation, already during low/moderate exercise intensity. This does not concern heart, where huge cytosolic P i accumulation never takes place because of the limited total phosphate pool. Single complex deficiencies. The conclusions drawn in the present theoretical study apply not only to entire OXPHOS deficiencies but also to single OXPHOS complex deficiencies. The main difference is that the changes of the system observed, namely a given decrease in V O 2 and changes in metabolite concentrations, especially in cytosolic P i , occur at much higher single complex deficiencies than entire OXPHOS deficiencies. This was demonstrated in the previous theoretical study (32) for complex IV and ATP synthase at moderate and heavy exercise in skeletal muscle, but this concerns essentially all OXPHOS complexes both in skeletal muscle and heart. Additionally, a given complex deficiency can be partly compensated by an increase in other complex concentrations/activities, which would further attenuate the effect of the deficiency. The present study is focused on entire OXPHOS deficiencies as they are most common and have a stronger effect than single complex deficiencies.
Other possible reasons for the greater skeletal muscle than heart vulnerability to OXPHOS deficiencies. The present theoretical study offers a novel mechanism that can contribute to the earlier (at higher relative OXPHOS activities) and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart, namely a much higher cytosolic P i level (accumulation) (possibly together with higher cytosolic ADP and H ϩ levels) in the former. This difference is very important, as cytosolic P i and, to a smaller extent, ADP and H ϩ are factors responsible for fatigue and/or force decrease in skeletal muscle (1, 12, 19, 43, 53, 65) and potentially limiting force generation in heart (60) .
However, other factors can contribute to this tissue specificity of mitochondrial diseases, namely different proportion of defective mtDNA molecules in different tissues (54, 62, 63) , mutations affecting OXPHOS selectively in certain tissues (40, 54) , different wild-type levels of enzymes affecting the amount of (normal) mtDNA and OXPHOS complexes (11, 57) , different relative maximum ATP usage in relation to OXPHOS capacity (61, 64) , and different relative amounts/activities of particular OXPHOS complexes in different tissues (3, 8, 49) . Additionally, in some cases, heart can be more affected than skeletal muscle, for instance in the case of mutations specific for cardiomyopathies (54) . Therefore it is not claimed in the present study that different cytosolic P i concentrations (as well as ADP and H ϩ concentrations) at low OXPHOS activities are the only factor/mechanism that leads to different OXPHOS deficiency manifestations in skeletal muscle and heart.
On the other hand, the role of some of the enumerated factors/mechanisms is uncertain. First, there is no evidence that mutated mtDNA is preferentially distributed to certain tissues-probably the different defective mtDNA and OXPHOS complex proportions in different tissues derive from random mtDNA molecule transfer to descendant cells during cell divisions in early stages of embryonic development. Therefore mutated DNA molecules can be more abundant in different tissues in different individuals (54) . Second, most mutations lead to preferential development of mitochondrial diseases in skeletal muscle than in heart. Third, while the maximum V O 2 /oxidative ATP turnover seems to be higher in skeletal muscle than in heart, especially when recalculated for the mitochondria content/basic activity, it is reasonable to suppose that ESA is more intensive (A OX is higher) in heavily exercising muscle than in intensively working heart. Additionally, at significant OXPHOS deficiencies neither in skeletal muscle nor in heart is the maximum work intensity/ATP demand approached, and the different cytosolic P i accumulation (level) in skeletal muscle and heart does not depend significantly on ATP demand (see above). Finally, the tissue differences in relative OXPHOS complex amounts/activities are important only for the tissue specificity of mitochondrial diseases related to mutations in particular complex subunit-encoding genes, while the majority of mitochondrial diseases are caused by the entire OXPHOS deficiencies related to mutations in mt-tRNA genes, by mutations in genes controlling the amount of (normal) mtDNA, and by large deletions in mtDNA (54, 58, 61) .
NADH increases moderately between 100 and 20% of normal OXPHOS activity. As the dependence of reactive oxygen species (ROS) seems to depend steeply on NADH, this could lead to elevated ROS production that could cause cell damage (6) . However, the increase in OXPHOS deficiency-related NADH level seems to be comparable in skeletal muscle and heart (Table 1 ) and therefore cannot contribute significantly to the faster and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart.
OXPHOS deficiencies and work transitions in skeletal muscle and heart. A high OXPHOS deficiency causes not only changes in V O 2 , metabolite concentrations, and pH but also significantly slows down the V O 2 on-kinetics during rest-tomoderate work (ATP demand) transition in skeletal muscle and lower-to-higher work (ATP demand) transition in heart (Figs.  3 and 4) . The characteristic transition time p is much shorter in intact heart (4 -8 s) (59) than in skeletal muscle (10 -50 s) (66) at 100% of normal OXPHOS activity. This experimental finding was confirmed by theoretical computer-aided studies (28, 38) . The discussed difference is caused by the fact that a "perfect" ESA takes place in heart, while a mixed mechanism is present in skeletal muscle (see above). As a result of this, . Schematic presentation of the postulated reasons of the difference in cytosolic Pi level at high OXPHOS deficiencies between skeletal muscle and heart and its role for different mitochondrial diseases manifestation in these tissues. In skeletal muscle, a much higher cytosolic Pi and higher PCr (both related to higher total phosphate pool) at normal OXPHOS activity as well as little Pi redistribution between cytosol and mitochondria (that occupy ϳ7% of cell volume) lead to a high cytosolic Pi level at OXPHOS deficiency that compromises power generation by actomyosin-ATPase. In heart, a much lower cytosolic Pi and lower PCr at normal OXPHOS activity as well as pronounced Pi redistribution between cytosol and mitochondria (that occupy ϳ23% of cell volume) lead to a moderate cytosolic Pi level at OXPHOS deficiency that does not compromise power generation by actomyosin-ATPase. Here, cyt, cytosolic compartment; mit, mitochondrial compartment.
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metabolite concentrations are essentially constant during work transitions in intact heart in vivo, while they change moderately during rest-to-work transition in skeletal muscle at 100% of OXPHOS activity. It was demonstrated that, at a given oxidative ATP supply flux, the half-transition time t 1/2 for V O 2 (proportional to p ) is proportional to changes in metabolite concentrations, especially PCr (or Cr) and total P i , during work transitions (38) . During rest-to-moderate exercise (ATP demand) transition at 20% of OXPHOS activity the simulated t 1/2 for muscle V O 2 is over three times longer (ϳ62 vs. 18 s) than at 100% of wild-type OXPHOS activity. This is related to much higher changes in PCr and total P i concentrations at 20% than at 100% of OXPHOS activity, to a lower oxidative ATP production flux, and to the elevated ATP supply by anaerobic glycolysis. A similar effect was encountered in experimental studies, where average pulmonary p was much higher in subjects with mitochondrial myopathies (MM) (59.2 s) than in control healthy subjects (35.4 s) for "moderate" external work intensity (power output) (18) (particular MM patients had most probably different OXPHOS deficiencies). This finding indirectly confirms the theoretical prediction concerning the high cytosolic P i accumulation (and PCr decrease) in subjects with mitochondrial myopathies. Also lactic acidosis is a typical syndrome of mitochondrial myopathies (13, 45, 57, 63) , which confirms the model predictions.
The untypical (not exponential) V O 2 on-kinetics at 20% of OXPHOS intensity is due to the first quick phase of V O 2 increase caused by ESA (ESA intensity is the same for 100 and 20% of normal OXPHOS activity) and the second slow phase caused by the low OXPHOS activity.
It should be emphasized that under pathological conditions the external mechanical work intensity (power output, P.O., in W) and ATP usage related to it must not be identified with (or assumed to be strictly proportional to) the total ATP usage or oxidative ATP supply (or V O 2 ). There are two main ATP-using processes in working muscle, actomyosin-ATPase and Ca 2ϩ -ATPase, which contribute to a comparable extent to the overall ATP usage. At high levels of cytosolic P i , ADP, and H ϩ the efficiency of power generation can decrease (the amount of ATP molecules hydrolyzed per a unit of mechanical work generated by actomyosine, or the mechanistic ATP/P.O. ratio, can increase). As a result, the overall V O 2 /P.O. ratio would increase. Additionally, the relative contribution of Ca 2ϩ -ATPase (SERCA) to ATP usage can increase, decreasing the contribution of actomyosin-ATPase. Moreover, SERCA amount/activity upregulation could be a compensatory mechanism in patients with mitochondrial diseases. This would increase the phenomenological ATP/P.O. ratio and the overall V O 2 /P.O. ratio. On the other hand, in the presence of high OXPHOS deficiencies, ATP supply by anaerobic glycolysis can constitute a substantial fraction of the total ATP supply even at relatively low total ATP demand and external mechanical work, as is predicted in the present simulations. Glycolysis would be activated by elevated cytosolic ADP (and also AMP and P i ) levels. This possibility is confirmed by the observation that blood lactate in patients with mitochondrial myopathies (MM) during as low absolute external (loaded) work as ϳ40 W is elevated about twice in relation to healthy controls performing the same relative (in relation to maximum P.O.) external (loaded) work, although the absolute value of this work in this subject group is much higher: ϳ90 W (18). Generally, lactic acidosis is a widely recognized syndrome of mitochondrial myopathies (13, 45, 57, 63 (18) . This fact further supports the model prediction that anaerobic glycolysis supplies substantial amounts of ATP during even "moderate-intensity" (in relative terms) or lowintensity (in absolute terms) external work in MM patients. However, as discussed above, this low external (mechanical) work can potentially correspond to moderate ATP demand, because of an impairment of ATP-using processes. However, the decrease in the ⌬V O 2 /⌬P.O. ratio between unloaded and loaded work in MM patients encountered by Grassi et al. (18) testifies that the effect of the recruitment of anaerobic ATP supply on the ⌬V O 2 /⌬P.O. ratio prevails over the potential effect of ATP usage impairment. Additionally, no slow component of the V O 2 on-kinetics was observed in MM patients in this study, suggesting that actomyosin-ATPase and Ca 2ϩ -ATPase were not significantly impaired and the overall ATP/ P.O. ratio did not progressively increase during exercise, which is the case during heavy/severe exercise in normal subjects, where impairment of ATP-consuming processes leading to "additional" ATP usage was postulated [compare Grassi et al. (19) and Korzeniewski and Rossiter (36) ].
In skeletal muscle, NADH decreases after the onset of exercise both at 100 and 20% of normal OXPHOS activity. This is the result of a stronger activation of the NADHconsuming system (ATP usage ϩ OXPHOS) than of NADH supply. However, when in computer simulations NADH supply is activated more than NADH consumption, the NADH level can increase, as was actually observed in some studies [see Korzeniewski (29) for a detailed discussion].
A qualitatively similar situation takes place in heart. It can be seen that an 80% OXPHOS deficiency slows down the low-to-medium work (ATP demand) transition in relation to healthy control (t 1/2 for V O 2 increases from 3.7 to 5.3 s). However, the relative effect is not as big as in skeletal muscle. While metabolite concentrations and pH are essentially constant during the transition at 100% of normal OXPHOS activity, they change slightly at 20% of normal OXPHOS activity.
NADH is essentially constant in the simulations concerning low-to-moderate transition in heart, for both 100 and 20% of the normal OXPHOS activity. In isolated heart trabeculae a significant transient NADH undershoot after electrical or Ca 2ϩ -related stimulation ("on-undershoot") was observed, while after the cessation of stimulation a NADH overshoot ("off-overshoot") was present (5) . Such an undershoot/overshoot can easily be generated by the computer model used in the present study when a significant delay in the activation/ inactivation of NADH supply (long characteristic activation/ inactivation time) in relation to the activation/inactivation of NADH consumption during on-/off-transient is assumed (28) . However, there is no reason to suppose that such a delay takes place in intact heart in vivo. The regulation of the system can be very different even in perfused heart vs. intact heart in vivo. While in the latter case metabolite (PCr, ADP, P i , NADH) concentrations are essentially constant during work transitions, they change significantly in the former case [see, e.g., Korze-Tissue Specificity of Mitochondrial Diseases in Muscle vs. Heart • Korzeniewski B. niewski (28) for discussion]. Therefore the kinetic behavior of the system in isolated trabeculae or single cells should not be directly extrapolated to intact heart. The same concerns skeletal muscle. For this reason, in the simulations carried out in the present study a short characteristic activation time is used (see METHODS) .
The lengthening of t 1/2 / p for V O 2 at low OXPHOS activity in skeletal muscle is a derivative of much greater changes in metabolite concentrations, especially in PCr and total P i , during work transitions than at normal OXPHOS activity (and also of a lower oxidative ATP supply and higher glycolytic ATP supply) (38) . It can be seen that during rest-to-moderate exercise (ATP demand) transitions in skeletal muscle, PCr and cytosolic P i change much more at 20% than at 100% of normal OXPHOS activity (Fig. 3) . In heart, while metabolite concentrations and pH are essentially constant during the low-tomedium work (ATP demand) transition at 100% of OXPHOS activity, they change very moderately at 20% of OXPHOS activity (Fig. 4) . Therefore, in this case, the characteristic activation time of OXPHOS (see METHODS) is likely to contribute significantly to determination of t 1/2 .
Computer simulations predict that the half-transition time for V O 2 during on-transient (t 1/2 ) in skeletal muscle is inversely proportional to OXPHOS activity and that the relationship between them is nonlinear (Fig. 5) . This prediction indirectly confirms the observation by Grassi et al. (18) that there is a kind of threshold in the relationship between the characteristic transition time for V O 2 () and oxygen extraction as well as V O 2 peak. The "threshold" observed in Fig. 5 is slightly less pronounced than in these experimental relationships. However, there is no reason to suppose that O 2 extraction and V O 2 peak depend linearly on OXPHOS activity. In particular, there is only correlation, but not a causal link, between oxygen extraction and V O 2 peak and t 1/2 . A causal link exists between OXPHOS activity, changes in PCr and P i during rest-to-work transition, oxidative ATP supply during work, and t 1/2 . Generally, the impact of OXPHOS activity on t 1/2 was modeled by Korzeniewski and Zoladz (38) , although not for such low OXPHOS activities. Grassi et al. (18) proposed that "determination of pulmonary V O 2 kinetics during transitions to constant-load moderate-intensity exercise allows to identify and also to quantify, noninvasively, the limitation to skeletal muscle metabolism." The present theoretical study confirms to a large extent this proposal.
The t 1/2 -OXPHOS activity relationship shown in Fig. 5 is similar to the on Ϫ V O 2 max relationship observed by Wüst et al. in single frog muscle fibers stimulated electrically (68) (see Fig. 3B therein) . Although this system is very different from the intact human skeletal muscle during voluntary exercise system modeled in the present study, this experimental finding seems to confirm the theoretical predictions.
Tissue specificity of mitochondrial diseases in different tissues. The conclusions drawn in the present study in relation to skeletal muscle vs. heart can also be referred to other tissues/organs. The bioenergetic systems of skeletal muscle and heart are generally similar. Both have the same main ATPases (actomyosin-ATPase and Ca 2ϩ -ATPase) that are possibly inhibited (directly or indirectly) by high cytosolic P i levels; possess the creatine kinase system (CK ϩ PCr ϩ Cr); and are characterized by a high maximum ATP usage and high variations in ATP turnover rate. This is not the case for many other tissues. For instance, nonexcitable tissues, such as liver and kidney, are characterized by low relative changes in ATP turnover (for instance, V O 2 increases only up to 1.3 times after hepatocyte stimulation by vasopressin; 7) and are devoid of the CK system. Therefore relatively much smaller changes in cytosolic P i , ADP, and H ϩ can be expected in them. They also have different main ATP-utilizing processes (gluconeogenesis and ureagenesis in liver or Na ϩ /K ϩ -ATPase in kidney) that are perhaps not so sensitive to cytosolic P i concentration. Indeed, these tissues are relatively little vulnerable to OXPHOS deficiencies. A rather low PCr level (5-6 mM, decreasing to ϳ1 mM in hypoglycemia) and total creatine (PCr ϩ Cr) pool (ϳ9 mM) is found in the brain tissue (47) . This means that as large cytosolic P i accumulation at OXPHOS deficiencies as in skeletal muscle cannot be expected here. Therefore, in this case, a high maximum relative energy (ATP) usage and the specific main ATP-hydrolyzing process (Na ϩ /K ϩ -ATPase, sensitive to the ATP/ADP ratio; 44) may be the key features responsible for the preferential development of mitochondrial encephalopathies (42). Generally, cytosolic P i seems to be an important factor able to account for the different vulnerability of skeletal muscle and heart to OXPHOS deficiencies, but it does not necessarily play such a role in other tissues. In other words, it seems likely that there is no one universal factor responsible for the tissue specificity of mitochondrial diseases and that this specificity has different underlying mechanisms for different (pairs of) tissues.
Study limitations. Any computer model of a complex real system always constitutes a certain simplification and approximation of this system. The model used in the present study, although extensively validated, does not take into account explicitly the (possibly varying) efficiency of actomyosinATPase (ATP/mechanical work ratio) and the contribution of Ca 2ϩ -ATPase to ATP usage, but only the total ATP demand. Therefore it can involve only the dependence of the system on ATP demand but not the relation between ATP demand (or V O 2 ) and external mechanical work. The fact that type II muscle fibers become fatigued earlier than type I muscle fibers is also not taken into account explicitly. There exist compensatory mechanisms in patients with mitochondrial diseases, for instance an increased blood flow and O 2 extraction (18, 20) , that are not taken into account within the model. To the author's knowledge, the cytosolic P i accumulation (concentration) has not been studied in the context of (the specificity of) mitochondrial diseases, and therefore this article can only offer a new testable proposition. However, these limitations do not affect the general conclusions drawn in the present study concerning the possible role of cytosolic P i in the (tissue specificity of the) etiology of mitochondrial diseases. Of course, the potential correctness of the above proposition will have to be validated or falsified by appropriate experimental studies.
In the present theoretical study, mostly (a broad range of) moderate exercise intensity and 80% OXPHOS deficiency in skeletal muscle was analyzed. However, at even greater OX-PHOS deficiencies a huge cytosolic P i decrease, and thus mitochondrial myopathy manifestation, should be expected even at low work intensities.
Conclusions. Summing up, the present study postulates a novel mechanism that can contribute to the statistically faster (at higher relative OXPHOS activities) and stronger manifes-Tissue Specificity of Mitochondrial Diseases in Muscle vs. Heart • Korzeniewski B. tation of mitochondrial diseases caused by OXPHOS deficiencies in skeletal muscle than in heart. Namely, this is a much higher cytosolic inorganic phosphate (P i ) concentration at high OXPHOS deficiencies in skeletal muscle than in heart in a broad range of work intensity (ATP demand). The cytosolic P i level at low OXPHOS activity in skeletal muscle and heart does not depend significantly on particular ATP demand (work intensity), because under these conditions most PCr is already converted to P i and Cr, and little further P i could be produced. The much higher cytosolic P i concentration in skeletal muscle than in heart at low OXPHOS activity in a broad range of ATP demand is caused by a much higher cytosolic P i concentration and higher PCr level at normal OXPHOS activity in skeletal muscle than in heart (both related to a much greater total phosphate pool in skeletal muscle) and by a much greater redistribution of P i between cytosol and mitochondria at low OXPHOS activities in the latter. As cytosolic P i is considered to be the most important fatigue-development factor in skeletal muscle and was shown to be able to severely limit force generation in skeletal muscle and heart cells, it is an attractive candidate for a major factor contributing to the tissue specificity of mitochondria diseases in the context of the skeletal muscle vs. heart. The much lower cytosolic P i accumulation in heart at low OXPHOS activity could evolve as a protective mechanism that prevents heart failure or arrest in hypoxia. Also, higher levels of cytosolic ADP and H ϩ at low OXPHOS activities can contribute, although to a lesser extent, to fatigue development/force limitation in skeletal muscle and thus to the etiology of mitochondrial myopathies. Simply speaking, it is postulated that skeletal muscle with large OXPHOS deficiencies becomes fatigued, because of high cytosolic P i accumulation, already at low/moderate exercise intensity. This does not concern heart, where the huge cytosolic P i accumulation never takes place because of the limited total phosphate pool. Nevertheless, cytosolic P i (and ADP and H ϩ ) is not claimed to be the only relevant factor in this case and is not likely to play any important role in other tissues (e.g., liver, kidney, or brain).
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